Alere Inc.
Alere Inc., a prominent player in the diagnostics industry, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1999, Alere has established itself as a leader in rapid diagnostic testing, particularly in areas such as infectious diseases, cardiology, and toxicology. The company is renowned for its innovative point-of-care testing solutions, which provide timely and accurate results, enabling healthcare professionals to make informed decisions swiftly. Alere's commitment to advancing healthcare through technology has led to significant milestones, including the development of unique products that enhance patient outcomes. With a strong market position, Alere Inc. continues to be recognised for its contributions to the healthcare sector, making it a trusted name in diagnostics worldwide.
DitchCarbon Score
How does Alere Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Alere Inc.'s score of 55 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Alere Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Abbott Laboratories, which may influence its climate commitments and reporting practices. While Alere Inc. has not established its own reduction targets or climate pledges, it is important to note that any potential targets or initiatives may be cascaded from Abbott Laboratories. Abbott has set science-based targets (SBTi) that guide its subsidiaries in aligning with global climate goals. However, specific details regarding these targets for Alere Inc. are not disclosed. In summary, Alere Inc. lacks publicly available emissions data and specific climate commitments, relying on the broader initiatives of its parent company, Abbott Laboratories, for guidance on sustainability and emissions reduction.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 578,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 691,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | - | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Alere Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
